← Back to Search

N/A

Almonds for Overweight Active Older Adults

N/A
Recruiting
Led By Bahram Arjmandi, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 50-59 years
Free of any chronic diseases such as cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study the effects of almond consumption on energy expenditure, performance, and related outcomes in active, overweight older adults, compared to a control snack.

Who is the study for?
This trial is for active, overweight adults aged 50-59 with a BMI of 25.0 to 29.9 kg/m2 who are free from chronic diseases like cancer and cardiovascular conditions. Participants should not be on certain medications, have musculoskeletal issues that limit activity, or be involved in other studies.Check my eligibility
What is being tested?
The study tests if eating almonds twice daily for 12 weeks can improve energy use, physical performance, vascular function, inflammation levels, sleep quality, mood status and body composition in active older adults compared to a similar calorie control snack.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort or allergic reactions due to almond consumption; however specific side effects related to the intervention are not detailed in the provided information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 59 years old.
Select...
I do not have any chronic diseases, including cancer.
Select...
I am a physically active man or a postmenopausal woman.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of almonds on functional performance
Effect of almonds on submaximal aerobic capacity (VO2)
Secondary outcome measures
Effect of Almond on arterial health using flow mediated dilation
Effect of Almond on arterial health using pulse wave velocity
Effect of Almond on oxidative stress
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Almond supplementExperimental Treatment1 Intervention
Participants will consume 32 g dry roasted, unsalted almonds twice a day for 12 weeks
Group II: Placebo matched supplementPlacebo Group1 Intervention
Participants will consume 100 g granola bar, calorie matched to Almond, twice a day for 12 weeks

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
202 Previous Clinical Trials
31,736 Total Patients Enrolled
17 Trials studying Obesity
1,354 Patients Enrolled for Obesity
Almond Board of CaliforniaOTHER
34 Previous Clinical Trials
2,171 Total Patients Enrolled
7 Trials studying Obesity
439 Patients Enrolled for Obesity
Bahram Arjmandi, PhDPrincipal Investigator - Florida State University
Florida State University
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top